Related Experiment Video
Updated: Aug 29, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients
Duygu Selcen1, Kinji Ohno, Andrew G Engel
1Department of Neurology, Neuromuscular Research Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Selcen.Duygu@mayo.edu
Abstract:
The term myofibrillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, alphaB-crystallin (alphaBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and alphaBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 +/- 16 years (mean +/- SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle fibres are best identified in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, alphaBC, dystrophin and beta-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z-disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and alphaBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of alphaBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.
Insights
Myofibrillar myopathy (MFM) is a muscle disorder characterized by myofibrillar dissolution. Genetic analysis reveals it is morphologically distinct but genetically heterogeneous, with mutations found in desmin and alphaB-crystallin.
Area of Science:
- Neurology
- Pathology
- Genetics
Background:
- Myofibrillar myopathy (MFM) is a pathological pattern of myofibrillar dissolution with protein accumulation.
- Previous studies identified dominant mutations in desmin and alphaB-crystallin (alphaBC) in some MFM patients.
- MFM presents with diverse clinical manifestations and varying genetic underpinnings.
Purpose of the Study:
- To review the clinical, structural, and genetic features of 63 unrelated MFM patients.
- To identify common diagnostic markers and underlying genetic causes of MFM.
- To explore the relationship between MFM subtypes and specific protein abnormalities.
Main Methods:
- Retrospective review of clinical data, muscle biopsies, and genetic analyses from 63 MFM patients (1977-2003).
- Histopathological examination using trichrome staining and immunohistochemistry for desmin, alphaBC, myotilin, dystrophin, and beta-amyloid precursor protein.
- Genetic analysis for mutations in desmin, alphaBC, telethonin, and syncoilin.
Main Results:
- Average age of onset was 54 years, with 77% experiencing proximal and distal weakness.
- Muscle fibers showed amorphous hyaline structures and vacuoles; 90% overexpressed myotilin.
- Genetic analysis identified mutations in alphaBC (2 patients) and desmin (4 patients), confirming genetic heterogeneity.
Conclusions:
- Myofibrillar myopathy is morphologically distinct but genetically heterogeneous.
- Immunohistochemistry for myotilin, desmin, and alphaBC aids in MFM diagnosis.
- Further research into Z-disk proteins is needed to elucidate the molecular causes of MFM.
Related Concept Videos
Types of Intermediate Filaments
Classification of Skeletal Muscle Fibers
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Alterations in Muscle Tone lll
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

